GSK plc Buys Back Own Shares
Ticker: GLAXF · Form: 6-K · Filed: Mar 28, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | Mar 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-buyback, stock-transaction
TL;DR
GSK is buying back its own stock via Citigroup.
AI Summary
GSK plc announced on March 28, 2025, that it has purchased a number of its own ordinary shares through its corporate stockbroker, Citigroup Global Markets Limited. The filing does not specify the exact number of shares or the total dollar amount involved in these transactions.
Why It Matters
Share buybacks can signal management's confidence in the company's valuation and potentially increase earnings per share.
Risk Assessment
Risk Level: low — This is a routine disclosure of share repurchases and does not indicate any new or significant risks.
Key Players & Entities
- GSK plc (company) — The company making the announcement and repurchasing shares.
- Citigroup Global Markets Limited (company) — The corporate stockbroker acting on behalf of GSK plc for the share purchases.
- March 28, 2025 (date) — The date of the announcement and the transactions.
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K filing reports on GSK plc's transactions in its own shares, specifically the purchase of ordinary shares.
Who is acting as GSK's stockbroker for these share purchases?
Citigroup Global Markets Limited is acting as GSK plc's corporate stockbroker for these transactions.
On what date did GSK plc announce these share purchases?
GSK plc announced these share purchases on March 28, 2025.
Does the filing specify the number of shares GSK plc purchased?
No, the filing states that GSK plc has purchased 'the following number of the Company's ordinary shares' but does not list the specific number in the provided text.
What is the par value of GSK plc's ordinary shares mentioned in the filing?
The ordinary shares of GSK plc mentioned in the filing have a par value of 31 1/4 pence each.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 28, 2025 regarding GSK plc (GLAXF).